isabelobrien, Author at European Medical Journal - Page 10 of 65

Could psychedelic medicine solve the mental health crisis?

Explore the evolving role of MDMA, LSD and psilocybin in traditional medical research, particularly in the realm of mental health.

Illustrated handshake

BMS appoints new EVP, CMO and Head of Development

Bristol Myers Squibb announces the appointment of Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of Development.

Steven Okoli

Hema Now: Episode 22: The State of Sickle Cell

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

A colourful flat illustration of a woman in a lab coat looking down at a pestle and mortar, plants, pills and tinctures

Pharma’s role in the rise of wellness misinformation

Wellness trends are outpacing science and endangering lives. As trust in traditional medicine erodes, pharma must step in to correct the narrative.

Dr Daejin Adiboye

AbbVie's Dr Daejin Abidoye on community and compassion in cancer care

AbbVie’s Daejin Abidoye reflects on his 20-year journey in oncology – from clinical insights to advances in precision medicine in the cancer space.

A colourful flat illustration of a woman looking into a microscope

Daiichi Sankyo’s Laura McMullin appointed ABPI Vice President

Laura McMullin, General Manager, Daiichi Sankyo UK, has been appointed the new Vice President of the ABPI.

WHO: unequal vaccine rates put children at risk

WHO and UNICEF report finds that global childhood vaccination coverage held steady in 2024, but that worrying gaps remain.

5 minutes with Graham Clark, CEO, Phastar

Graham Clark, CEO, Phastar, explores the current state of play in clinical research, the future of AI in the field and values-based business.

Shish Patel, Chiesi

Chiesi's Shish Patel on COPD, the climate and improving care

What is the environmental cost of respiratory illness? In this episode, Shish Patel, Medical Director, Chiesi UK joins Isabel to explore this and COPD’s rising burden.

Survey shows pharma leaders backing AI and RWD

A new survey has found that the use of AI and real-world data (RWD) is on the rise across the biopharma industry, but hurdles remain.